Ibrahim M. Abu-Reidah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ibrahim M. Abu-Reidah has a total of 285 co-authors. Here are the top co-authors by number of shared publications:
- Antonio Segura-Carretero
Department of Analytical Chemistry, University of Granada, 18071 Granada, Spain
15 shared publications - David Arráez-Román
Department of Analytical Chemistry, University of Granada, 18071 Granada, Spain
12 shared publications - Alberto Fernández-Gutiérrez
Department of Analytical Chemistry, Faculty of Science, University of Granada, Ave. Fuentenueva s/n, 18071 Granada, Spain
10 shared publications - Ismail Warad
Department of Chemistry, Science College, An-Najah National University, Nablus, Palestine
6 shared publications - Mohammed Saleem Ali-Shtayeh
Biodiversity & Environmental Research Center, BERC, Nablus, Palestine
4 shared publications - Rana Majed Jamous
Biodiversity & Environmental Research Center, BERC, Nablus, Palestine
4 shared publications
Latest Publications
- Open Access
- 6 November 2026
- Published by SAGE Publications in Journal of Chemical Research
- Vol. 50 (6)
Synthesis and In vitro anticancer, antibacterial, and antifungal activities of novel thymol derivatives
Five thymol esters were synthesized and characterized using Fourier-transform infrared (FT-IR), 1 H nuclear magnetic resonance (NMR), and 13 C NMR spectroscopy. Their in vitro anticancer activities were evaluated against colorectal (Caco-2), hepatocellular (HepG2), cervical (HeLa), and breast (MCF-7) cancer cell lines, with LX-2 cells used as a non-malignant comparator. Antibacterial activity was assessed against methicillin-resistant Staphylococcus aureus (MRSA), S. aureus , Klebsiella pneumoniae , Escherichia coli , Proteus vulgaris , and Pseudomonas aeruginosa ; antifungal activity was assessed against Candida albicans. J16 showed an IC 50 of 64.97 μg/mL (249.55 μM) against HepG2 cells. J14 showed IC 50 values of 63.36 μg/mL (213.8 μM), 47.38 μg/mL (159.87 μM), and 66.46 μg/mL (224.25 μM) against Caco-2, HeLa, and MCF-7 cells, respectively. The reported IC 50 of J14 in LX-2 cells was 240.82 μg/mL (812.61 μM). J14 showed strong activity against MRSA , S. aureus , and C. albicans , although the organism-specific minimum inhibitory concentrations (MICs) require confirmation against the underlying data. J12 inhibited K. pneumoniae and E. coli at MICs of 0.38 and 0.75 mg/mL, respectively; J12 and J16 inhibited P. vulgaris at 0.38 mg/mL. These in vitro findings suggest that selected thymol esters warrant further investigation. Additional mechanisms, selectivity, and in vivo studies are required before therapeutic conclusions can be drawn.
- 6 November 2026
- Published by SAGE Publications in Journal of Chemical Research
- Vol. 50 (6)
Open AccessSynthesis and In vitro anticancer, antibacterial, and antifungal activities of novel thymol derivatives
Five thymol esters were synthesized and characterized using Fourier-transform infrared (FT-IR), 1 H nuclear magnetic resonance (NMR), and 13 C NMR spectroscopy. Their in vitro anticancer activities were evaluated against colorectal (Caco-2), hepatocellular (HepG2), cervical (HeLa), and breast (MCF-7) cancer cell lines, with LX-2 cells used as a non-malignant comparator. Antibacterial activity was assessed against methicillin-resistant Staphylococcus aureus (MRSA), S. aureus , Klebsiella pneumoniae , Escherichia coli , Proteus vulgaris , and Pseudomonas aeruginosa ; antifungal activity was assessed against Candida albicans. J16 showed an IC 50 of 64.97 μg/mL (249.55 μM) against HepG2 cells. J14 showed IC 50 values of 63.36 μg/mL (213.8 μM), 47.38 μg/mL (159.87 μM), and 66.46 μg/mL (224.25 μM) against Caco-2, HeLa, and MCF-7 cells, respectively. The reported IC 50 of J14 in LX-2 cells was 240.82 μg/mL (812.61 μM). J14 showed strong activity against MRSA , S. aureus , and C. albicans , although the organism-specific minimum inhibitory concentrations (MICs) require confirmation against the underlying data. J12 inhibited K. pneumoniae and E. coli at MICs of 0.38 and 0.75 mg/mL, respectively; J12 and J16 inhibited P. vulgaris at 0.38 mg/mL. These in vitro findings suggest that selected thymol esters warrant further investigation. Additional mechanisms, selectivity, and in vivo studies are required before therapeutic conclusions can be drawn.
- Open Access
Special Issue on “Phytochemicals: Extraction, Optimization, Identification, Biological Activities, and Applications in the Food, Nutraceutical, and Pharmaceutical Industries”
There is growing interest in using natural plant extracts in foods and beverages due to their ability to enhance the quality of food and provide therapeutic benefits
Open AccessSpecial Issue on “Phytochemicals: Extraction, Optimization, Identification, Biological Activities, and Applications in the Food, Nutraceutical, and Pharmaceutical Industries”
There is growing interest in using natural plant extracts in foods and beverages due to their ability to enhance the quality of food and provide therapeutic benefits
- Open Access
Effect of Spirulina Microalgae Powder in Gluten-Free Biscuits and Snacks Formulated with Quinoa Flour
This study evaluated the effects of incorporating spirulina algae powder (SAP) at 3%, 6%, and 9% into quinoa flour (QF) blends to produce gluten-free biscuits and snacks, compared to a 100% QF control. The chemical composition, mineral and amino acid content, antioxidant capacity, starch gelatinization, color, baking quality, sensory properties, and texture were analyzed. SAP was found to have high protein (62.50%), fat (5.92%), and ash (12.90%) content. Increasing the SAP concentration in QF blends resulted in a dose-dependent enhancement in the nutritional value of the biscuits and snacks. Farinograph analysis indicated a positive relationship between SAP percentage and water absorption. The inclusion of SAP significantly altered differential scanning calorimetry (DSC) and viscoamylograph parameters. Biscuit weight, volume, and specific volume decreased with increasing SAP levels. Hunter color measurements showed a SAP concentration-dependent darkening effect, which was supported by sensory assessments. The 9% SAP biscuits and snacks exhibited the greatest antioxidant activity, with DPPH values of 50.18 and 43.6 µmol/g, respectively, and reducing power values of 41.49 and 36.58 µmol/g, respectively. Overall, while all samples were deemed acceptable, the 3% and 6% SAP formulations generally demonstrated better sensory characteristics and improved nutritional profiles, suggesting their potential as suitable options for individuals with gluten sensitivities.
Open AccessEffect of Spirulina Microalgae Powder in Gluten-Free Biscuits and Snacks Formulated with Quinoa Flour
This study evaluated the effects of incorporating spirulina algae powder (SAP) at 3%, 6%, and 9% into quinoa flour (QF) blends to produce gluten-free biscuits and snacks, compared to a 100% QF control. The chemical composition, mineral and amino acid content, antioxidant capacity, starch gelatinization, color, baking quality, sensory properties, and texture were analyzed. SAP was found to have high protein (62.50%), fat (5.92%), and ash (12.90%) content. Increasing the SAP concentration in QF blends resulted in a dose-dependent enhancement in the nutritional value of the biscuits and snacks. Farinograph analysis indicated a positive relationship between SAP percentage and water absorption. The inclusion of SAP significantly altered differential scanning calorimetry (DSC) and viscoamylograph parameters. Biscuit weight, volume, and specific volume decreased with increasing SAP levels. Hunter color measurements showed a SAP concentration-dependent darkening effect, which was supported by sensory assessments. The 9% SAP biscuits and snacks exhibited the greatest antioxidant activity, with DPPH values of 50.18 and 43.6 µmol/g, respectively, and reducing power values of 41.49 and 36.58 µmol/g, respectively. Overall, while all samples were deemed acceptable, the 3% and 6% SAP formulations generally demonstrated better sensory characteristics and improved nutritional profiles, suggesting their potential as suitable options for individuals with gluten sensitivities.
- Open Access
- 16 February 2025
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1334
Synthesis, characterization, anticancer, antibacterial and antioxidant activities of novel thymol ester compound
- 16 February 2025
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1334
Open AccessSynthesis, characterization, anticancer, antibacterial and antioxidant activities of novel thymol ester compound
- Open Access
- 21 October 2024
- Published by SAGE Publications in Natural Product Communications
- Vol. 19 (10)
Phytochemical Components, Hindering Abilities on Cell Proliferation, Cell Migration and Three-Dimensional Spheroids’ Formation Capacity of Micromeria fruticosa Infusion
Objectives: The objective of this study was to investigate the potential anti-cancer effects of Micromeria fruticosa plant infusion on uterine cervix cancer cells, aiming to explore its potential as an alternative or supportive therapeutic approach to conventional treatments. Methods: Micromeria fruticosa plant infusion was prepared and administered to uterine cervix cancer cells in vitro. Various assays were conducted to assess its impact on cell migration, proliferation, and tumorigenicity. Additionally, the phytochemical composition of the infusion was analyzed by using LC-MS to identify major functional compounds. Results: The study revealed that Micromeria fruticosa plant infusion exhibited significant anti-migratory, anti-proliferative, and anti-tumorigenic effects on uterine cervix cancer cells. Analysis of the infusion identified several major functional phytochemicals, which likely contribute to its anticancer properties. Conclusion: This research suggests that Micromeria fruticosa plant infusion possesses promising anti-cancer properties against uterine cervix cancer cells. The identified phytochemicals present in the infusion highlight its potential as a source of functional ingredients with anticancer effects. These findings support further exploration of Micromeria fruticosa as a potential therapeutic agent in both nutraceutical and pharmaceutical applications, offering new avenues for the development of alternative or supportive treatments for cervical cancer.
- 21 October 2024
- Published by SAGE Publications in Natural Product Communications
- Vol. 19 (10)
Open AccessPhytochemical Components, Hindering Abilities on Cell Proliferation, Cell Migration and Three-Dimensional Spheroids’ Formation Capacity of Micromeria fruticosa Infusion
Objectives: The objective of this study was to investigate the potential anti-cancer effects of Micromeria fruticosa plant infusion on uterine cervix cancer cells, aiming to explore its potential as an alternative or supportive therapeutic approach to conventional treatments. Methods: Micromeria fruticosa plant infusion was prepared and administered to uterine cervix cancer cells in vitro. Various assays were conducted to assess its impact on cell migration, proliferation, and tumorigenicity. Additionally, the phytochemical composition of the infusion was analyzed by using LC-MS to identify major functional compounds. Results: The study revealed that Micromeria fruticosa plant infusion exhibited significant anti-migratory, anti-proliferative, and anti-tumorigenic effects on uterine cervix cancer cells. Analysis of the infusion identified several major functional phytochemicals, which likely contribute to its anticancer properties. Conclusion: This research suggests that Micromeria fruticosa plant infusion possesses promising anti-cancer properties against uterine cervix cancer cells. The identified phytochemicals present in the infusion highlight its potential as a source of functional ingredients with anticancer effects. These findings support further exploration of Micromeria fruticosa as a potential therapeutic agent in both nutraceutical and pharmaceutical applications, offering new avenues for the development of alternative or supportive treatments for cervical cancer.
- Open Access
- 29 September 2024
- Published by MDPI AG in Nutraceuticals
- Vol. 4 (4) , 450-468
Promising Phytoconstituents in Antiangiogenesis Drug Development
Angiogenesis, the process of forming new blood vessels from existing ones, is crucial in both physiological and pathological conditions, such as tumor growth, metastasis, and inflammatory disorders. Targeting angiogenesis has emerged as a promising therapeutic strategy. Recent research has increasingly focused on the role of bioactive components found in food in regulating angiogenesis, although there are certain limitations. This review provides a comprehensive examination of the origins, composition, pharmacological activities, and mechanisms of action of these components in medicinal foods, reflecting the growing intersection of medicine and nutrition. The goal is to aid in preventing angiogenesis-related complications and fostering healthier habits. The insights offered in this review aim to advance the development of effective, low-toxicity antiangiogenic drugs. Additionally, there has been a notable rise in interest in plant-derived compounds with antiangiogenic properties. This review investigates the potential of phytoconstituents from plants as drug candidates targeting angiogenesis, exploring their mechanisms of action, the research conducted thus far, and the challenges associated with transitioning these compounds into clinical applications.
- 29 September 2024
- Published by MDPI AG in Nutraceuticals
- Vol. 4 (4) , 450-468
Open AccessPromising Phytoconstituents in Antiangiogenesis Drug Development
Angiogenesis, the process of forming new blood vessels from existing ones, is crucial in both physiological and pathological conditions, such as tumor growth, metastasis, and inflammatory disorders. Targeting angiogenesis has emerged as a promising therapeutic strategy. Recent research has increasingly focused on the role of bioactive components found in food in regulating angiogenesis, although there are certain limitations. This review provides a comprehensive examination of the origins, composition, pharmacological activities, and mechanisms of action of these components in medicinal foods, reflecting the growing intersection of medicine and nutrition. The goal is to aid in preventing angiogenesis-related complications and fostering healthier habits. The insights offered in this review aim to advance the development of effective, low-toxicity antiangiogenic drugs. Additionally, there has been a notable rise in interest in plant-derived compounds with antiangiogenic properties. This review investigates the potential of phytoconstituents from plants as drug candidates targeting angiogenesis, exploring their mechanisms of action, the research conducted thus far, and the challenges associated with transitioning these compounds into clinical applications.
- Open Access
- 11 February 2024
- Published by MDPI AG in Antioxidants
- Vol. 13 (2) , 225
Enrichment of Whole-Grain Breads with Food-Grade Extracted Apple Pomace Bioactives Enhanced Their Anti-Inflammatory, Antithrombotic and Anti-Oxidant Functional Properties
Apple pomace (AP) is a bio-waste product of apples that is co-produced as a by-product during apples’ processing for making apple-based products, mainly apple juice, cider and vinegar. AP is a rich source of several bioactives that can be valorized as ingredients for developing novel functional foods, supplements and nutraceuticals. Within the present study, food-grade extracts from AP with different tannin contents were found to contain bioactive polar lipids (PLs), phenolics and carotenoids with strong anti-oxidant, antithrombotic and anti-inflammatory properties. The extract from the low-in-tannins AP showed stronger anti-inflammatory potency in human platelets against the potent thrombo-inflammatory mediator platelet-activating factor (PAF), while it also exhibited considerable anti-platelet effects against the standard platelet agonist, adenosine diphosphate (ADP). The infusion of 0.5–1.0 g of this bioactive AP extract as functional ingredients for whole-grain bread-making resulted in the production of novel bio-functional bread products with stronger anti-oxidant, antithrombotic and anti-inflammatory potency against both PAF and ADP in human platelets, compared to the standard non-infused control breads. Structural analysis by LCMS showed that the PL-bioactives from all these sources (AP and the bio-functional breads) are rich in bioactive unsaturated fatty acids (UFA), especially in the omega-9 oleic acid (OA; 18:1n9), the omega-3 alpha linolenic acid (ALA; 18:n3) and the omega-6 linoleic acid (LA; 18:2n6), which further supports their strong anti-inflammatory and antithrombotic properties. All food-grade extracted AP including that infused with AP-bioactives novel functional breads showed higher hydrophilic, lipophilic and total phenolic content, as well as total carotenoid content, and subsequently stronger antioxidant capacity. These results showed the potential of appropriately valorizing AP-extracts in developing novel bio-functional bakery products, as well as in other health-promoting applications. Nevertheless, more studies are needed to fully elucidate and/or validate the anti-inflammatory, antithrombotic and antioxidant potential of novel bio-functional products across the food and cosmetic sectors when infused with these AP bioactives.
- 11 February 2024
- Published by MDPI AG in Antioxidants
- Vol. 13 (2) , 225
Open AccessEnrichment of Whole-Grain Breads with Food-Grade Extracted Apple Pomace Bioactives Enhanced Their Anti-Inflammatory, Antithrombotic and Anti-Oxidant Functional Properties
Apple pomace (AP) is a bio-waste product of apples that is co-produced as a by-product during apples’ processing for making apple-based products, mainly apple juice, cider and vinegar. AP is a rich source of several bioactives that can be valorized as ingredients for developing novel functional foods, supplements and nutraceuticals. Within the present study, food-grade extracts from AP with different tannin contents were found to contain bioactive polar lipids (PLs), phenolics and carotenoids with strong anti-oxidant, antithrombotic and anti-inflammatory properties. The extract from the low-in-tannins AP showed stronger anti-inflammatory potency in human platelets against the potent thrombo-inflammatory mediator platelet-activating factor (PAF), while it also exhibited considerable anti-platelet effects against the standard platelet agonist, adenosine diphosphate (ADP). The infusion of 0.5–1.0 g of this bioactive AP extract as functional ingredients for whole-grain bread-making resulted in the production of novel bio-functional bread products with stronger anti-oxidant, antithrombotic and anti-inflammatory potency against both PAF and ADP in human platelets, compared to the standard non-infused control breads. Structural analysis by LCMS showed that the PL-bioactives from all these sources (AP and the bio-functional breads) are rich in bioactive unsaturated fatty acids (UFA), especially in the omega-9 oleic acid (OA; 18:1n9), the omega-3 alpha linolenic acid (ALA; 18:n3) and the omega-6 linoleic acid (LA; 18:2n6), which further supports their strong anti-inflammatory and antithrombotic properties. All food-grade extracted AP including that infused with AP-bioactives novel functional breads showed higher hydrophilic, lipophilic and total phenolic content, as well as total carotenoid content, and subsequently stronger antioxidant capacity. These results showed the potential of appropriately valorizing AP-extracts in developing novel bio-functional bakery products, as well as in other health-promoting applications. Nevertheless, more studies are needed to fully elucidate and/or validate the anti-inflammatory, antithrombotic and antioxidant potential of novel bio-functional products across the food and cosmetic sectors when infused with these AP bioactives.
- Open Access
Special Issue on “Secondary Metabolites: Extraction, Optimization, Identification and Applications in Food, Nutraceutical, and Pharmaceutical Industries”
There is a growing interest in utilizing natural plant extracts in the food and beverage industries
Open AccessSpecial Issue on “Secondary Metabolites: Extraction, Optimization, Identification and Applications in Food, Nutraceutical, and Pharmaceutical Industries”
There is a growing interest in utilizing natural plant extracts in the food and beverage industries
- 11 September 2023
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1295
Synthesis and biological evaluation of several new heterocyclic carvacrol esters
- 11 September 2023
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1295
Synthesis and biological evaluation of several new heterocyclic carvacrol esters
- Open Access
Hydroethanolic Extract of Urtica dioica L. (Stinging Nettle) Leaves as Disaccharidase Inhibitor and Glucose Transport in Caco-2 Hinderer
Herbal treatment for diabetes mellitus is widely used. The pharmacological activity is thought to be due to the phenolic compounds found in the plant leaves. The present study aims to investigate the phytochemical composition of Urtica dioica (UD) hydroethanolic extract and to screen its antidiabetic activity by disaccharidase hindering and glucose transport in Caco-2 cells. The results have shown that a total of 13 phenolic compounds in this work, viz. caffeic and coumaric acid esters (1, 2, 4–7, 10), ferulic derivative (3), and flavonoid glycosides (8, 9, 11–13), were identified using HPLC-DAD-ESI/MS2. The most abundant phenolic compounds were 8 (rutin) followed by 6 (caffeoylquinic acid III). Less predominant compounds were 4 (caffeoylquinic acid II) and 11 (kaempferol-O-rutinoside). The UD hydroethanolic extract showed 56%, 45%, and 28% (1.0 mg/mL) inhibition level for maltase, sucrase, and lactase, respectively. On the other hand, glucose transport was 1.48 times less at 1.0 mg/mL UD extract compared with the control containing no UD extract. The results confirmed that U. dioica is a potential antidiabetic herb having both anti-disaccharidase and glucose transport inhibitory properties, which explained the use of UD in traditional medicine.
Open AccessHydroethanolic Extract of Urtica dioica L. (Stinging Nettle) Leaves as Disaccharidase Inhibitor and Glucose Transport in Caco-2 Hinderer
Herbal treatment for diabetes mellitus is widely used. The pharmacological activity is thought to be due to the phenolic compounds found in the plant leaves. The present study aims to investigate the phytochemical composition of Urtica dioica (UD) hydroethanolic extract and to screen its antidiabetic activity by disaccharidase hindering and glucose transport in Caco-2 cells. The results have shown that a total of 13 phenolic compounds in this work, viz. caffeic and coumaric acid esters (1, 2, 4–7, 10), ferulic derivative (3), and flavonoid glycosides (8, 9, 11–13), were identified using HPLC-DAD-ESI/MS2. The most abundant phenolic compounds were 8 (rutin) followed by 6 (caffeoylquinic acid III). Less predominant compounds were 4 (caffeoylquinic acid II) and 11 (kaempferol-O-rutinoside). The UD hydroethanolic extract showed 56%, 45%, and 28% (1.0 mg/mL) inhibition level for maltase, sucrase, and lactase, respectively. On the other hand, glucose transport was 1.48 times less at 1.0 mg/mL UD extract compared with the control containing no UD extract. The results confirmed that U. dioica is a potential antidiabetic herb having both anti-disaccharidase and glucose transport inhibitory properties, which explained the use of UD in traditional medicine.